Literature DB >> 32803461

C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma.

Varun Moktan1, Emily Jonica2, Zhou Li3, Donna Jane Hata4, Francis A Farraye5.   

Abstract

Entities:  

Year:  2021        PMID： 32803461     DOI： 10.1007/s10620-020-06496-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.

Authors:  Dana J Lukin; Garrett Lawlor; David P Hudesman; Laura Durbin; Jordan E Axelrad; Monica Passi; Kimberly Cavaliere; Elliot Coburn; Michelle Loftus; Henry Jen; Alexandra Feathers; Melissa H Rosen; Lisa B Malter; Arun Swaminath
Journal:  Inflamm Bowel Dis       Date:  2019-03-14       Impact factor: 5.325

Review 2.  Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.

Authors:  Sahil Khanna; Andrea Shin; Ciarán P Kelly
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02       Impact factor: 11.382

3.  Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer.

Authors:  Mini Kamboj; Jennifer Brite; Tracy McMillen; Elizabeth Robilotti; Alejandro Herrera; Kent Sepkowitz; N Esther Babady
Journal:  J Infect       Date:  2017-12-08       Impact factor: 6.072

4.  Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.

Authors:  Meeta Desai; Kristin Knight; James M Gray; Vu Nguyen; James Boone; Dario Sorrentino
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-09       Impact factor: 2.566

5.  AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Joseph D Feuerstein; Kim L Isaacs; Yecheskel Schneider; Shazia Mehmood Siddique; Yngve Falck-Ytter; Siddharth Singh
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

6.  The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome.

Authors:  Kerrie A Davies; Tim Planche; Mark H Wilcox
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.